Collecting cells and biomarkers from ALS patients
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study collects samples (blood, skin, urine) from people with ALS to create cell banks and find biomarkers. It helps researchers learn more about the disease and may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with ALS
- You are willing and able to give consent
- You do not have a bleeding disorder or take blood thinners
- You are not allergic to lidocaine
- You are covered by a health insurance or social security plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study builds a blood and spinal fluid (lumbar puncture) sample library from people with ALS, ALS-FTD, or similar neurodegenerative diseases. Your samples help researchers study these conditions, even if you are not receiving a new treatment.
Hear when a new Amyotrophic Lateral Sclerosis (ALS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.